HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Free All Versions of this Article: 105/5/1389    most recent 90408.2008v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Younes, M. Search for Related Content PubMed PubMed Citation Articles by Younes, M.

REVIEW

Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders

Sleep Centre, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada

ABSTRACT

Obstructive sleep disorders develop when the normal reduction in pharyngeal dilator activity at sleep onset occurs in an individual whose pharynx requires a relatively high level of dilator activity to remain sufficiently open. They range from steady snoring, to slowly evolving hypopneas, to fast-recurring obstructive hypopneas and apneas. A fundamental observation is that the polysomnographic picture differs substantially among subjects with the same pharyngeal collapsibility, and even in the same subject at different times, indicating that the type and severity of the disorder is determined to a large extent by the individual's response to the obstruction. The present report reviews the various mechanisms involved in the response to sleep-induced obstructive events. When the obstructive event takes the form of mild-moderate flow limitation, compensation can take place through an increase in the fraction of time spent in inspiration (TI/Ttot) without any increase in maximum flow (_MAX). With more severe obstructions, _MAX must increase. Recent data indicate that the obstructed upper airway can reopen reflexly, without arousal, if chemical drive is allowed to reach a threshold (T_ER) but that this is often preempted by a low arousal threshold. The relation between T_ER and arousal threshold, as well as the lung-to-carotid circulation time and the rate of rise of chemical drive during the obstructive event, determine the magnitude of ventilatory overshoot at the end of an event and, by extension, whether initial obstructive events will be followed by stable breathing, slow evolving hypopneas with occasional arousals, or repetitive events.

arousal threshold; effective recruitment threshold; obstructive sleep apnea; upper airway resistance syndrome

Obstructive phenomena are very common. For example, habitual snoring with intermittent hypopnea/apneas occurs in 52% of women and 64% of men (134), while 4% of women and 9% of men develop >15 discrete obstructive events per hour (134). Not all affected individuals suffer clinical consequences, but there is convincing evidence that these disorders adversely affect quality of life and cognitive function in many patients (85). As well, there is growing evidence that the risk for hypertension and its complications is increased in affected individuals (31, 85).

The pharynx of patients with obstructive sleep disorders is, on average, smaller and more collapsible than in others (26, 40, 45, 94, 95). During wakefulness, this is compensated for through appropriate increases in dilator muscle activity (71, 107). In fact, these patients have no breathing difficulty while awake. For example, obstructive sleep apnea (OSA) patients achieve normal maximum exercise levels (49, 63, 64) even though this requires flow rates > 4 l/s (cf. <0.5 l/s during sleep). The fundamental reason for development of obstructive sleep disorders is that the increase in dilator activity observed in wakefulness is substantially lost at sleep onset (27, 72). In subjects with more favorable pharyngeal mechanics, dilator activity also decreases at sleep onset (27, 110, 124), but airway size does not decrease enough to interfere with flow requirements during sleep. Thus these disorders develop when the normal reduction in dilator activity at sleep onset occurs in a subject whose pharynx requires relatively high dilator activity to remain sufficiently open.

A critically important observation is that the polysomnographic features vary considerably among patients with the same degree of pharyngeal collapsibility (45, 127) and even vary in the same patient at different times during sleep (127). These observations indicate that how an individual responds to the sleep-induced obstruction determines to a large extent the type and severity of the disorder (127). This review will be concerned primarily with the mechanisms that determine the response to sleep-induced obstructions, and hence the polysomnographic manifestations of the disorder.

MECHANICAL CHARACTERISTICS OF THE PASSIVE PHARYNX

An understanding of the mechanical properties of the passive human pharynx is essential to this topic because it is these passive properties that determine whether, and by how much, pharyngeal dilators must be activated to maintain adequate ventilation. Except at its extreme upper and lower ends, where it is anchored to bone and cartilage (larynx), respectively, the human pharynx has no rigid support. Accordingly, throughout most of its length its cross-sectional area varies with lumen pressure (44, 45). The pressure-area relation of the passive human pharynx has been studied in detail (44, 45). In all humans a certain lumen pressure can be found at which the passive pharynx is completely closed (P_Close) (44, 45). Above P_Close, the relation between area and pressure is nonlinear such that pharyngeal compliance (area/P_LUMEN; A/P) decreases as pressure and area increase (44, 45; Fig. 1A). P_Close and the shape of the pressure-area relation vary considerably among individuals, with the four curves shown in Fig. 1A representing most of the spectrum (45). As can be seen, at atmospheric airway pressure (P_AW = 0) passive pharyngeal area can be large (top curve) or small (middle curves), or the pharynx may be completely closed. A number of fixed skeletal and soft tissue features have been identified that may account for the differences in passive mechanical behavior. Furthermore, the passive behavior of the pharynx may change in the same individual in response to changes in body and neck position, lung volume (caudal traction), edema, vascularity, and surface tension properties. A review of these factors is beyond the scope of this article (see Refs. 21, 46, 56, 60, 85, 88, 94, 97, 108, 109, 113, 127, 135).

View larger version (10K): [in this window] [in a new window]   Fig. 1. A: relation between external airway pressure and minimum pharyngeal cross-sectional area in 4 subjects, representing the spectrum of passive mechanical properties of the pharynx. PClose, pressure at which the pharynx is closed. Constructed from data in Ref. 45. B: relation between external airway pressure and maximum flow conducted by the upper airway (MAX). Lines A, B, C, and D provide the spectrum seen in patients with obstructive sleep disorders (constructed from data in Ref. 127). The dashed line represents a subject who would have no obstructive abnormality during sleep. MAX0, maximum flow that can be conducted in the absence of pharyngeal dilator activity in the subject breathing with no external pressure applied.

Maximum flow in collapsible tubes is determined by tube area (A), tube compliance (A/P), and gas density () according to the following equation [tube law (20, 123)]:

(1)

Thus _MAX is directly related to tube area and inversely related to tube compliance. Because as luminal pressure increases, pharyngeal area increases and its compliance simultaneously decreases (Fig. 1A), the relation between luminal pressure and _MAX is not so nonlinear and is, in fact, close to a linear relation over the flow range relevant to sleeping subjects (12, 86, 98) (see footnote 2 for a discussion of tube law vs. the Starling resistor model).² This greatly simplifies the situation since the mechanical properties of an individual's pharynx can be described simply by an intercept (P_Close) and a slope of the pressure-_MAX relation (12, 86, 98). Early determinations of this relation were made by measuring _MAX at different levels of constant sustained airway pressure (29, 100, 103). Because compensatory mechanisms were allowed to evolve at each pressure level before _MAX was measured, the reported slope and intercept did not characterize the passive pharynx but, rather, the combined passive and active properties of the pharynx. Such measurements, therefore, could not be used to identify the separate roles played by passive (i.e., structural) properties and control mechanisms in the pathogenesis of OSA. More recently, measurement of _MAX during the first few breaths after a reduction of continuous positive airway pressure (CPAP) (dial down) has been used to advantage to determine the passive mechanical properties of the pharynx (12, 86, 98, 127–129). This approach is based on the observations that on CPAP, dilator activity is minimal (57, 88, 95) and remains unchanged for 2–3 breaths following reduction of CPAP (62, 91, 98, 106). Thus, by briefly reducing CPAP to different levels and observing _MAX, one can conveniently estimate the relation between external P_AW and _MAX in the passive pharynx with reasonable accuracy (91, 98, 127).

Figure 1B shows a range of P_AW-_MAX relations observed in sleeping subjects in whom the brief dial-down approach was used (e.g., 98, 127). Consistent with endoscopic measurements in the passive pharynx (e.g., 46), P_Close ranges from less than –10 to 10 cmH₂O (127). The slope, which reflects the shape of the pressure-area relation (see footnote 2), is also highly variable, ranging from 16 to 103 l·s^–1·cmH₂O^–1 (127). A particularly useful value obtained from such plots is _MAX at an external airway pressure of zero (_MAX0, Fig. 1B). _MAX0 indicates what maximum flow would be during unassisted breathing if pharyngeal dilator influence declined to zero during sleep. Accordingly, this term incorporates the combined effects of P_Close and the slope of the relation in the nearly passive pharynx and, further, takes into account any pressure drop between the external airway and the site of flow limitation (i.e., upstream or nasal resistance). In essence, it embodies in one value the effect of all the anatomic factors that determine susceptibility to OSA (127).

An additional advantage of _MAX0 is that it can be very rapidly determined from a few brief dial down(s) to near atmospheric pressure. If the dial downs to atmospheric pressure result in complete obstruction, a few more dial downs to higher pressures may be added to determine the value of P_Close (e.g., 129). This simple approach is to be contrasted with the multiple observations over a wide range of pressures (including negative pressures) required previously to determine P_Close and the slope (12, 29, 86, 89, 98, 100, 103). _MAX0, so determined, is also fairly consistent within a given patient/body position combination (127). By being so easily and rapidly obtained, it allows a bottom-line assessment of passive pharyngeal properties that can be readily and repeatedly performed in standard clinical laboratories (e.g., 127). This should make it possible to evaluate passive mechanics under different conditions in the same night (e.g., different body positions, sleep stages, time of night, and the effect of various pharmacological or mechanical interventions).

RELATION BETWEEN PASSIVE PHARYNGEAL PROPERTIES AND POLYSOMNOGRAPHIC SEVERITY OF OSA

There are only a few studies that evaluated this relation (22, 45, 60, 127). In other studies (e.g., 29, 32, 100) pharyngeal mechanics were not determined under passive conditions. In all four relevant studies (22, 45, 60, 127) there was a significant positive relation between apnea-hypopnea index (AHI) and some index of collapsibility of the pharynx. However, the relation showed considerable scatter in all cases. Pressure-area data obtained under anesthesia/paralysis by Isono et al. (45) showed considerable overlap among patients with severe, mild, or no OSA. When P_Close (45) or P_CRIT (60) was used as the index of collapsibility, it accounted for only 14% to 21% of the variability in the respiratory disturbance index (r² = 0.14 and 0.21 in the 2 studies, respectively). Although with use of the more comprehensive descriptor of passive properties (_MAX0) the relation was stronger, much of the variance in the AHI was still unrelated to passive pharyngeal mechanics (r² = 0.28 for _MAX0 vs. AHI; Ref. 127). These findings indicate that the response to the abnormally collapsible pharynx plays a more important role in determining the polysomnographic picture than the severity of the anatomic problem. In the following sections the response to the obstructive events, and how this may affect the polysomnographic features, will be discussed.

COMPENSATORY MECHANISMS AVAILABLE TO RESTORE VENTILATION FOLLOWING A SLEEP-INDUCED OBSTRUCTIVE EVENT

Even the mildest hypopnea, conventionally defined as a 50% reduction in breathing amplitude (1) [which the author considers as 50% reduction in tidal volume (VT)], would result in near doubling of arterial PCO₂ (PaCO₂) and severe desaturation unless some compensatory mechanism is engaged to restore ventilation. More significant events would be inconsistent with life in the absence of such compensatory mechanisms. One very important compensatory mechanism is arousal from sleep (90, 93). Arousal removes the precipitating cause of the obstruction and is associated with a substantial increase in dilator activity (10, 14, 61, 93), thereby restoring ventilation. Although arousal is an effective safeguard against life-threatening asphyxia, such a compensatory mechanism has the disadvantage that the obstruction will recur once the subject returns to sleep. Thus, without arousal-independent mechanisms, even the patient with the mildest form of anatomic compromise would be doomed to a constantly interrupted sleep.

In order for arousal-independent mechanisms to succeed, they must be able to restore minute ventilation (E) to a sustainable level without arousal. A sustainable E is one with which the changes in blood gas tensions in the steady state are not enough to trigger arousal. Sustainable E is between 80 and 95% of the unloaded ventilatory demand (see online supplement in Ref. 127) with the range largely reflecting how much change in gas tensions can be sustained without arousal (arousal threshold). Unloaded ventilatory demand during sleep (e.g., E on optimal CPAP) varies among individuals [3.8–9.3 l/min (127, 129)], reflecting differences in metabolic rate, dead space ratio, and CO₂ set point. Arousal threshold also varies greatly among patients (5, 6, 54, 80, 99, 112, 121, 129, 136) and at different times in the same patient (6). Thus, for a given abnormality in passive mechanics (e.g., _MAX0), the challenge facing the compensatory mechanisms varies between and within subjects.

E is the product of mean inspiratory flow rate (VT/TI) and inspiratory duty cycle (TI/Ttot) (73, 96):

(2)

It follows that when an obstructive event develops, E may be increased toward the sustainable level through either an increase in duty cycle or an increase in mean inspiratory flow rate. In the presence of pharyngeal flow limitation, the latter can be accomplished only through activation of pharyngeal dilators. These two avenues will now be discussed.

Compensation via an Increase in Inspiratory Duty Cycle

With sustained flow limitation, TI/Ttot increases (47, 96, 104, 112, 121). An increase in duty cycle has the effect of increasing ventilation in the absence of any increase in _MAX since the patient spends a greater fraction of time inspiring (Eq. 2). Figure 2 is an example of how effective this can be. While the patient was on CPAP (Fig. 2, left), peak flow was 0.48 L/s and E was 7.2 l/min. On dial down of CPAP, flow became limited and _MAX was 0.18 l/s, or 37% of peak unloaded flow. VT decreased from 0.46 to 0.20 liter, or 43% of eupneic VT. Because respiratory rate did not change, the immediate decrease in E was also to 43% of the eupneic value. TI/Ttot increased gradually from 0.38 immediately after dial down (similar to the value on CPAP) to 0.61 a few minutes later (Fig. 2, right) while _MAX remained the same (37% of peak unloaded flow). As a result, E increased from an initial 3.1 l/min at the onset of hypopnea to 6.0 l/min later on, reaching 85% of baseline E on CPAP. This was associated with only a 5-mmHg increase in end-tidal PCO₂ (PETCO₂) and a 2% reduction in O₂ saturation. These values are consistent with a steady state. The change in chemical drive was clearly tolerated by this patient as evidenced by continued sleep. Thus in this case a _MAX of only 37% of peak unloaded flow was sustainable without arousal.

View larger version (39K): [in this window] [in a new window]   Fig. 2. Tracings from a patient to show how an increase in the fraction of time spent with inspiratory flow can make it possible to tolerate maximum flows that are well below peak flow in the unobstructed state. C3/A2, central electroencephalogram showing a continuous sleep pattern; ABD, abdomen; RC, ribcage; PMASK, mask pressure; TI/Ttot, fraction of time spent with inspiratory flow; RR, respiratory rate. Left: on dial down of continuous positive airway pressure (CPAP), the patient immediately developed an obstructive hypopnea where flow was <40% peak flow on CPAP and tidal volume (VT) was only 43% of VT requirement. With time (right; 5 min later), and despite no change in MAX, VT and ventilation returned to near baseline as a result of marked increase in the duration of inspiratory flow (note interval between vertical dashed lines). There were only modest changes in end-tidal PCO2 (PETCO2) and O2 saturation (O2 Sat), making a steady state possible. Inset: diagram showing how an increase in the amplitude of inspiratory efforts (more negative intrathoracic pressure) can increase TI/Ttot and the time during which flow is maximum even in the absence of any prolongation in neural inspiratory time. PMAX, intrathoracic pressure at which MAX is reached. The faster rate of reduction in intrathoracic pressure results in an earlier flow crossing from expiration to inspiration, and MAX is reached sooner (point c vs. point a). Likewise, intrathoracic pressure remains below PMAX for much of the declining phase of inspiratory effort (rising intrathoracic pressure), resulting in a delay in onset of expiratory flow and continued presence of MAX well beyond the point at which flow would have started to decline at the lower effort (point d vs. point b).

Because peak unloaded flow varies greatly among subjects [0.17–1.08 l/s (127)] and the fraction of peak flow that can be sustained also varies widely, sustainable _MAX varies greatly when expressed in actual flow units. For example, in a patient with a high ventilatory demand (e.g., peak unloaded flow = 0.7 l/s) and a low arousal threshold (sustainable _MAX = 70% peak unloaded flow), sustainable _MAX may be as high as 0.5 l/s. By contrast, for a patient with low ventilatory demand (peak unloaded flow = 0.20 l/s), a high arousal threshold, and favorable inspiratory effort shape (sustainable _MAX = 40% peak unloaded flow, e.g., Fig. 2), sustainable _MAX may be < 0.1 l/s. Furthermore, since some of the factors that determine sustainable _MAX change during the night in the same individual [e.g., arousal threshold (2)], sustainable _MAX may also vary from time to time during sleep.

Peak unloaded flow and sustainable _MAX of the patient illustrated in Fig. 2 are inserted in Fig. 1B to illustrate how these two variables interact with passive mechanics to determine the polysomnographic outcome in the absence of compensatory increase in _MAX. For a patient with these "control" characteristics, the anatomy represented by line A in Fig. 1B would be inconsequential. The anatomy represented by line B in Fig. 1B would result in moderately severe flow limitation, but a steady state can be reached without any active increase in _MAX. In a patient with the same "control" characteristics, an anatomy represented by lines C or D of Fig. 1B would be inconsistent with stable breathing unless _MAX increased to match sustainable _MAX through appropriate activation of pharyngeal dilators [see effective recruitment threshold (T_ER) below]. Clearly, the impact of the same anatomic abnormality would be different in a patient with different control characteristics. For example, line C of Fig. 1B may be associated with stable flow limitation in a patient whose sustainable _MAX is 0.1 l/s and, conversely, line B of Fig. 1B may be incompatible with steady breathing in a patient whose sustainable _MAX is >0.3 l/s. In a recent study (127), ventilatory demand on CPAP was found to be an independent determinant of the AHI. The higher AHI in obese subjects is in part related to their higher flow demand (127).

When _MAX0 is greater than sustainable _MAX, steady breathing would continue so long as arousal threshold remains high. A decrease in arousal threshold would increase sustainable _MAX and may make it impossible to reach the level of chemical drive required for a steady state (i.e., that associated with a high enough TI/Ttot). Arousal would then occur. The associated increase in ventilation would reduce chemical drive, returning TI/Ttot and E to a lower level, and the cycle repeats. Thus either steady breathing or recurrent hypopneas would follow depending on arousal threshold.

It can also be appreciated that if the respiratory neural responses to CO₂ and hypoxia are low, the changes in PaCO₂ and arterial PO₂ (PaO₂) required to increase inspiratory effort sufficiently for a steady state to occur through the duty cycle mechanism may be quite large. Because arousal is related to the intensity of effort and not to blood gas tensions, per se (30, 54), the patient may sleep through substantial deterioration of blood gas tensions, particularly if arousal threshold is also high. Such a combination (collapsible pharynx, low chemosensitivity, high arousal threshold) may underlie the obesity-hypoventilation syndrome.

Whereas the increase in duty cycle makes it possible to sustain a lower _MAX than would otherwise be the case, it is clear that this mechanism can, by itself, be effective only in dealing with relatively mild anatomic problems. Where _MAX is less than sustainable _MAX, including all cases where P_Close is positive, stable breathing can only occur through active dilatation of the pharynx. This introduces another level of complexity in that breathing stability is now dependent on how effective the control system is in raising _MAX and in keeping it high in a stable fashion.

Compensation via Reflex Increase in _MAX

Possible mechanisms for increasing _MAX.   As indicated earlier, once an obstructive event is initiated the only way to increase flow is through increased activation of pharyngeal dilators (see footnote 1). There are only two known mechanisms that can increase dilator activity during sustained sleep.

I) NEGATIVE PHARYNGEAL PRESSURE.   Negative pressure in the upper airway increases activity of the genioglossus in anesthetized animals (68) and in awake humans (38, 72, 118, 119). The gain of the reflex is reduced during sleep (37, 72, 118, 119). Nonetheless, there is evidence that this reflex contributes to activation of the dilators as chemical drive increases in the course of sleep-induced obstructive events (10, 77). Whether this reflex is weaker in OSA patients is unclear since available results are contradictory and limited to the awake state (11, 75).

II) INCREASE IN CHEMICAL DRIVE.   In sleeping animals, genioglossus activity increases in response to CO₂ inhalation (35, 39, 131). However, a finite increase in chemical drive above eupneic level must occur (threshold) before genioglossus activity increases (35, 39, 131). In awake normal subjects (82, 83), and awake OSA patients (77), genioglossus activity increases in response to CO₂ and hypoxia without an apparent threshold. Studies on the response of dilators to increased chemical drive during sleep in normal subjects have yielded conflicting results. In two studies (92, 105), hypoxia and hypercapnia did not increase genioglossus activity over the range of hypercapnia and hypoxia that is possible before arousal (50–70% increase in E), thereby suggesting the presence of a threshold. However, other studies do not show such a refractory range (65). The reason for these discrepancies among normal subjects is unclear.

In most OSA patients severe flow limitation or complete obstruction develops on a dial down from CPAP (127). Yet, dilator activity does not increase immediately (62, 91, 98, 106). This indicates that the negative pressure associated with eupneic drive (i.e., on CPAP) is insufficient to augment dilator activity. Pharyngeal pressure can become more negative only if pump muscles work harder, and, during sleep, this can only occur if chemical drive increases (126). Accordingly, an increase in chemical drive is necessary to increase dilator activity regardless of whether the immediate stimulus is chemical drive itself or the associated increase in negative pressure. This is a fundamental observation in that it indicates that for _MAX to increase without arousal, chemical drive must increase above the eupneic level and remain elevated above the level required to generate a sustainable _MAX. If drive increases above this level but decreases again below it when the airway opens, recurrent obstructions would result.

Will an increase in dilator activity without arousal necessarily increase _MAX?.   Dilator activity increases progressively in the course of obstructive events (10, 15, 61, 77, 84, 93). Yet, _MAX does not increase, and often decreases, for some time despite the clear increase in this activity. Remmers et al. (93) proposed their enduring "balance of forces" theory to explain this paradox. According to this mechanism, the increase in dilator action as chemical drive increases is more than offset by the concomitant increase in negative pharyngeal pressure tending to collapse the airway. Thus the balance of forces during chemical activation of the dilators is in favor of keeping the airway closed and remains so until a preferential activation of the dilators occurs through arousal. However, a number of recent observations indicate that activation of the dilators via an increase in chemical drive can prevail over the collapsing negative pressure if chemical drive is allowed to increase sufficiently. These observations will now be summarized:

I) Most patients with OSA develop periods of stable breathing and sleep (127). By itself, such a finding might be attributed to mild anatomic problems that can be offset part of the time without an increase in _MAX (for example as discussed in relation to Fig. 2). However, Younes (127) found that 78% of patients with OSA develop periods of stable breathing and sleep even though their _MAX0 was well below sustainable _MAX and was frequently zero (complete obstruction). Furthermore, the values of _MAX0 obtained over several hours were sufficiently stable to rule out the possibility that alternation between stable breathing and OSA was related to within-night changes in passive mechanics. Thus most patients currently diagnosed with OSA are capable of activating their dilators enough to increase _MAX to sustainable levels without the benefit of arousal.

II) The temporal relation between arousal and upper airway (UA) opening was examined in detail in the same patients (128). There was no arousal at or beyond opening in 17% of obstructive events (type 1 response) while in another 21% of events arousal followed, rather than preceded, UA opening (type 2 response). In either case, lack of arousal at the time of opening was ruled out by visual inspection and spectral analysis of the EEG, and by lack of heart rate increase up until UA opening.³ In the remaining 62%, arousal occurred at or before UA opening (type 3 response). The response type was not fixed in individual patients. Rather, most patients demonstrated two, or all three, response types at different times. The frequency of type 1 response (no arousal) increased, and that of type 3 decreased, as sleep depth increased (as indicated by delta power). Thus the relation between arousal and UA opening appeared to be incidental rather than a cause and effect relation. Even more importantly, the latency to UA opening (i.e., event duration) was the same whether arousal occurred before or after UA opening or did not occur at all (128).

III) Where UA opening occurred without or before arousal, the increase in flow was greater than that required to restore stable ventilation (128). Thus arousal is not needed to increase _MAX adequately.

From these observations, it was concluded that in most patients arousal is not necessary for adequate compensation but that arousals occurred because the increase in chemical drive required for reflex opening (henceforth called T_ER) overlaps with the range of increase in chemical drive that triggers arousal in these patients.

How much must chemical drive increase to reflexly open the airway (T_ER)?   Figure 3 shows examples of responses to dial down from air breathing in three OSA patients in whom arousal threshold was high. Here, chemical drive at the onset of the event was, by definition, eupneic drive. In all cases the initial response was complete obstruction. In patient A, the airway opened spontaneously without arousal on breath 3. Since the lung-to-carotid circulation delay is 2 breaths (129), it can be concluded that in this patient the airway can open reflexly as soon as chemoreceptors sense any deterioration in blood gas tensions relative to eupnea. Thus T_ER is essentially zero. In patient B, four obstructed breaths elapsed with no increase in flow despite a substantial increase in respiratory drive, as judged by the Respitrace signal.⁴ Flow appeared, with flow limitation, in breath 5 without arousal and increased much more in the next breath, still without arousal. In this case, T_ER was clearly >0 but was still less than arousal threshold. In patient C, flow did not appear until arousal occurred despite five breaths of increasing efforts. During another dial down when sleep was deeper, the airway opened, still at breath 6, but without arousal (not shown). Clearly, if in these patients arousal threshold were lower (e.g., arousal occurring during breaths 3 or 4), as it usually is (see below), opening by arousal would have preempted reflex opening in patients B and C, making it appear that arousal was the responsible mechanism.

View larger version (86K): [in this window] [in a new window]   Fig. 3. Response to a dial down from optimal CPAP in 3 patients with a relatively high arousal threshold. In each case, the dial-down pressure was set to be just below critical closing pressure (PClose), thereby resulting in a complete obstruction. C3/A2, central electroencephalogram. PAW, airway pressure. Patient A: opened the airway (arrow) without arousal after only 2 obstructed breaths. In patient B, the airway remained closed for 4 breaths despite increasing inspiratory efforts, as judged by the Respitrace signal. The airway opened with moderate flow limitation at breath 5, and flow increased much more at breath 6. Patient was in delta sleep throughout. While in stage 2 sleep, patient C remained obstructed for 5 breaths despite the marked increase in inspiratory effort. The airway opened following an arousal (heavy arrow). Note the different time scales in the 3 panels.

View larger version (16K): [in this window] [in a new window]   Fig. 4. Effect of increasing chemical drive before dial down on flow during dial down in 4 representative patients (A–D). , Dial-down flow when patient breathed air on CPAP. Note severe flow limitation in all cases. Dotted horizontal line, mean + 2SD of the response during air dial downs. , Dial-down flow when chemical drive was increased to different levels before dial down (abscissa) by changing inspired gas concentrations. TER, effective recruitment threshold, the increase in chemical drive above which dial-down flow became sensitive to further increases in drive. Note that different levels of stimulation were required in patients A–C to effectively dilate the airway, while in patient D maximum flow during dial down was unchanged despite a 3-fold increase in chemical drive. Modified from Ref. 129.

It may be argued that T_ER determined by the above method underestimates the increase in drive required to open the airway from an already obstructed state. This may be so because the pressure required for opening an already closed airway is higher than the pressure at which the airway closes starting from an open position (59, 79, 109, 122). However, if such a difference exists it cannot be large. Thus, in an earlier study (128), 59 of 82 patients (72%) opened the airway without arousal following at least one dial down (128). These dial downs started at eupneic respiratory drive (air breathing on CPAP) (128). In half these cases opening was from a completely obstructed state while in the other half the dial down was associated with hypopnea. The latency to airway opening was only 16.5 ± 8.0 s (range 6–43 s), and there was no difference between events with hypopnea and complete obstruction (16.5 ± 8.2 vs. 16.5 ± 7.9). Considering that 1) these dial downs began from eupneic drive, 2) all events were terminated before recirculation, and 3) the decrease in O₂ saturation was on average only 3% (128), the increase in drive at the time of opening (on average 7 s beyond the circulatory delay) could not have been much different from T_ER determined by increasing chemical drive before dial down of CPAP (e.g., Fig. 4).

Why is it necessary for chemical drive to increase a threshold amount (T_ER) before opening the airway, and why is T_ER so different among patients?   When the airway is completely obstructed (i.e., P_Close > 0), particularly if the tongue is impacted in the oropharynx, it is easy to see how, as postulated by Remmers et al. (93), the increase in suction pressure as chemical drive rises counteracts the increase in dilating force produced by dilators’ activation. Thus, opening can only occur if the dilators generated enough force to counteract the rising pump muscle pressure (which results in more negative pharyngeal pressure), plus any additional opening pressure requirements dictated by the passive mechanical properties, namely, P_Close and the viscous forces that resist opening (57, 58, 109, 122). This would clearly require the force generated by dilators to increase at a faster rate than the rate of increase in the collapsing negative pharyngeal pressure, thereby ultimately prevailing over it. It was initially felt that such a relatively greater activation of the dilators could only occur with arousals. The recent finding that in most patients the dilators can prevail over the opposing forces without arousal if chemical drive rises sufficiently (127–129) indicates that, in most patients, dilator force increases at a faster rate than the rate of increase in pump muscle pressure. Thus, when P_Close is >0, T_ER is likely a function of P_Close, viscous properties of the pharynx, and the relative rates of recruitment of pump and dilator muscles. To the extent that all these variables can differ among patients, T_ER can be quite different.

The situation is somewhat harder to explain when P_Close is <0. Here, the most that can happen is a hypopnea with flow limitation. In theory, with flow limitation, downstream pressure (i.e., the negative pressure generated by pump muscles) should be irrelevant and any dilating force applied at the site of flow limitation should increase _MAX. Several possibilities may explain failure of flow to increase during hypopneas despite the progressive increase in respiratory drive.

I) As in sleeping animals (35, 39, 131), a threshold increase in chemical drive may be needed before dilator activity can increase. Data in sleeping normal subjects are conflicting (65, 92, 105), and whereas many studies have documented a progressive increase in dilator activity during obstructive events in OSA patients (10, 15, 77, 83, 93), the chemical drive, relative to eupnea, at which recruitment begins in these patients has not been determined.

II) There are many dilator muscles that differ in their site of action and their pattern of activity and response to different stimuli (36, 48, 111, 120). The site of flow limitation differs among patients (74). Most data on dilator muscles’ activation were derived from easily accessible muscles (e.g., genioglossus). The specific dilator muscle(s) relevant to the site of flow limitation in a given individual may have different response characteristics from those that have been recorded from (48) and may require a higher chemical threshold for activation.

III) Even though the pharynx is not completely closed, expanding it may require a threshold dilating force to overcome "stickiness" of apposed mucosal folds.

IV) As mentioned earlier, negative effort dependence may occur during flow limitation (43). In such cases, the ability of the dilators to increase _MAX as chemical drive increases is compromised by the increasing negative pressure, tending to reduce _MAX. Thus, when negative effort dependence is present, _MAX can increase only when the increase in dilator force can cancel out the negative effect of increasing effort on _MAX. This may not occur until a threshold increase in chemical drive. The presence and magnitude of negative effort dependence appear to vary among OSA patients (43).

V) Regardless of the immediate reason for a T_ER (see I–IV, above), and whether the event is a hypopnea or apnea, an increase in _MAX can only occur when the force generated by the dilators prevails over opposing mechanical forces. The increase in dilator force as chemical drive increases is a function of the relation between chemical drive and dilator activity. This relation is clearly affected by the gain of the negative pressure reflex. With a stronger reflex, dilator activity should rise faster as chemical drive, and pharyngeal negative pressure, increase, and this should result in dilator force prevailing at a lower chemical drive (i.e., lower T_ER). In this respect it is noteworthy that the function of some pharyngeal mechanoreceptors that likely mediate the negative pressure reflex (36) is impaired in OSA patients (33, 55, 76). Thus differences in the potency of the negative pressure reflex may account, in part, for differences in T_ER among patients.

VI) The rate of increase in dilator force as chemical drive increases is also affected by the relation between dilator activity and the force generated by the muscles (i.e., dilators’ contractile properties). Thus, if the dilators were stronger, a lesser degree of activation (i.e., lesser chemical drive) would be required to prevail over the opposing mechanical forces. Inflammation and denervation (13) as well as impairment in the contractile properties (16) of pharyngeal dilators have been reported in OSA patients. Accordingly, differences in dilator muscles’ contractile properties may contribute to differences in T_ER among patients.

Recently, Patil et al. (87) compared OSA patients and normal subjects with respect to their ability to decrease critical closing pressure (P_CRIT) during sustained reductions in airway pressure. OSA patients failed to decrease P_CRIT whereas normal subjects did. This suggests that T_ER is higher in OSA patients than in normal subjects. Interestingly, the response of the genioglossus was not different, suggesting that the higher T_ER in OSA patients may be related to a mechanical threshold (see III and IV, above) or to impaired conversion of electrical activity to mechanical force (see mechanism VI, above). Further studies are clearly needed to elucidate the mechanism of T_ER.

MECHANISMS OF INSTABILITY IN OSA

If modest increases in chemical drive can open the airway without arousal, why do patients with OSA develop recurrent obstructions? For obstructive events to be prevented it is necessary that chemical drive remain continuously above the level required to obtain sustainable _MAX. For this to happen, flow cannot increase much above sustainable _MAX following airway opening. The occurrence of a significant ventilatory overshoot would wash away the chemical stimulus required to keep the airway open, setting the stage for another obstruction. Yet, OSA patients routinely develop an overshoot at the end of obstructive events. A recent study found that the increase in flow at airway opening was 2.56 ± 1.69 times the amount required to reach sustainable _MAX (128). Thus the reason why OSA patients develop recurrent obstructions when they do is that their ventilation overshoots the target on airway opening. Accordingly, as has been suggested earlier (67), OSA is an example of control system instability. The general mechanisms of ventilatory instability have been a subject of much study and modeling and have been reviewed extensively (17, 50, 53, 67, 125, 130). Much of the experimentation and modeling concerned central apneas (Cheyne-Stokes breathing). However, as has been theoretically suspected (e.g., 52, 67, 125), the instability of OSA differs from the usual periodic breathing in several important respects. 1) The ventilatory response to the blood gas changes that occur during and following obstructive event (i.e., controller gain) is not governed by the response of pump muscles and chest mechanics, which determine the classic ventilatory responses. Rather, it is governed primarily by the response of upper airway dilators and upper airway mechanics. Unlike the usual ventilatory responses, these are discontinuous responses (see Fig. 4), and the slope may be much steeper than the ventilatory responses that would obtain in the same individual with an open airway (125). 2) Arousals typically occur at the end of the event, thereby introducing additional complexity (50, 52, 67, 125). 3) Cycling frequency in not simply a function of circulatory delay, as is the case with simple periodic breathing, but is primarily related to the time it takes for the upper airway to open (see below). In the following account recent experimental data that have specifically addressed the mechanisms of the ventilatory overshoot (i.e., instability) in OSA will be reviewed.

Occurrence of Unnecessary Arousals

The occurrence of arousals in patients in whom the obstruction continues despite dangerous changes in blood gas tensions (i.e., very high T_ER) is unquestionably necessary and beneficial. However, and despite the fact that arousal threshold is higher in OSA patients than in normal subjects (3), in most patients who are currently diagnosed with OSA, arousal occurs in response to minimal, nonthreatening changes in gas tensions. In 82 OSA patients with mixed severity (AHI = 46 ± 35 h^–1) the average time to arousal following a CPAP dial down (i.e., beginning with eupneic blood gas tensions) was only 17.7 ± 11.0 s (128). At this time, O₂ saturation had decreased by only 3.1 ± 3.5% and PCO₂ at the chemoreceptors could not have increased by more than a few millimeters Hg above eupnea (128). In a more recent study (129), arousal threshold, defined as the increase in E above eupnea associated with arousal 50% of the time, was <10 l/min (6.3 ± 2.3 l/min) in 15 of 21 patients with very severe OSA. In the same patients, such increases in E could be produced within a few breaths of increasing PETCO₂ by 3.3 mmHg along with 4% decrease in O₂ saturation (129). Furthermore, because in most patients T_ER is reached with only modest blood gas changes, airway opening would still occur at very safe blood gas tensions in the absence of arousals (128). Thus, in a majority of patients, arousals are not needed and occur simply because arousal threshold is unnecessarily low.

Arousals dramatically increase the ventilatory overshoot in OSA patients (128). The effect of arousals on postevent flow is not all-or-none but varies with the intensity of arousal (Fig. 5). With barely noticeable arousals, the overshoot is slightly higher than in the absence of arousal, whereas with the most intense arousals, postevent flow is nearly four times what is required for stable breathing (Fig. 5). Arousals also vary in duration. Since the reduction in chemical drive during the ventilatory phase depends on the duration as well as the amplitude of overshoot, it may be expected that arousals of longer duration would increase the likelihood of instability.

View larger version (8K): [in this window] [in a new window]   Fig. 5. Impact of arousal intensity on the flow observed at airway opening following obstructive events. Flow is expressed as a ratio of flow at the time of opening to the flow required to maintain stable breathing, a response ratio of 1.0 being ideal. Intensity of 0 means no arousal. Intensity of 4 means most intense movement arousal. Note that the response is excessive (i.e., ventilatory overshoot exists) even without arousal and increases progressively with arousal intensity. Modified from Ref. 128.

In a recent study where both T_ER and arousal threshold were determined in the same patients, and both were expressed as the percent increase in eupneic E required for either response to occur, the two thresholds were, as predicted earlier (128), in the same general range but there was no correlation between them (129), indicating that the two responses involve different central mechanisms.

Magnitude of T_ER

The likelihood and extent of overshoot increase as T_ER increases. Assume that T_ER is 50% of eupneic drive. With an obstructive event the airway would open reflexly when inspiratory effort (i.e., negative intrathoracic pressure) is only 50% greater than eupneic level. Under such conditions the maximum possible overshoot, which would occur if upper airway resistance decreased to normal levels during the ventilatory phase, is 50% above eupneic ventilation. If resistance is not completely normalized during the ventilatory phase, the overshoot would be even less. With such a low T_ER, there would also be a smaller likelihood of arousal occurring during the ventilatory phase. Now, assume that T_ER is 200%. Here the potential for a large overshoot, up to 200% of eupneic ventilation if resistance is normalized, is clearly much greater when the airway opens and, since arousal is more likely to occur at such high drive levels, airway opening is more likely to be complete and the potential for reaching the maximum possible overshoot is thus greater. In this author's opinion, the magnitude of T_ER is the single most important variable that impacts the tendency to oscillate in the presence of abnormal pharyngeal mechanics.

Flow Response in the First Breath After Airway Opening in the Absence of Arousal

Flow usually increases abruptly in the first breath following an obstructive event. This discontinuous flow behavior supported the notion that arousals are the mechanism for airway opening. Recently, the magnitude of increase in flow at airway opening was measured when arousal was not present at the time (128). Although less than when arousal occurs, the discontinuous increase in flow was still evident in the first breath in many cases (128). In 69% of cases, flow during the first breath was greater than flow on CPAP. There was a wide range of these first-breath flow responses. These findings indicate that in some patients there is a sudden, very substantial reduction in airway resistance once T_ER is reached, even in the absence of arousal. Such a development would clearly promote an overshoot.

The mechanism for this discontinuous increase in flow during arousal-free airway opening is not clear. It is likely related to the same mechanism responsible for T_ER. In particular, it could be related to a mechanical threshold, such as the need to overcome viscid secretions between apposed mucosal surfaces, or to prevail over negative effort dependence. In the former case, once the dilators manage to unstick the apposed surfaces, the airway would pop open with a sudden large increase in flow. In the latter case, once the dilators manage to generate a force that overcomes the negative effort dependence, flow will increase. As a result, pharyngeal pressure becomes less negative, which in the presence of negative effort dependence further increases flow, and so on. Flow would thus increase rapidly through positive mechanical feedback.

Flow and E Beyond Breath 1

Typically, dilator activity decreases and upper airway resistance increases beyond the first open breath (15, 77). This is presumably because pharyngeal pressure is not as negative. A reduction in the intensity of arousal beyond breath 1 may also be a factor. This increase in resistance would tend to attenuate the overshoot. Mitigating these favorable changes is the tendency for chemical drive to continue increasing beyond the first open breath. This is because the blood gas tensions at the chemoreceptors at the time of opening reflect the gas tensions that existed in pulmonary blood some time before opening (i.e., lung-carotid circulation delay). In the interim, pulmonary gas tensions continue to deteriorate. Thus, depending on the transit time, chemoreceptors may continue to sense deterioration in gas tensions, and chemical drive may continue to increase, for a finite interval beyond breath 1. This would increase or prolong the overshoot because 1) arousal may be triggered after opening (e.g., later in breath 1 or in subsequent breaths) if it was not already present (128); 2) if arousal were present, its intensity and duration may increase; or 3) even without arousal the continued increase in chemical drive may attenuate or even reverse the increase in resistance that would otherwise occur beyond breath 1. The relation between chemical drive and _MAX (and hence E) beyond T_ER is highly variable and is often very steep (128; Fig. 4) so that even a small increase in drive beyond the point of opening may result in a large increase in flow and a much greater overshoot (e.g., Fig. 3B).

The magnitude of postevent increase in chemical drive depends on the lung-to-carotid circulation time and the rate of increase in chemical drive during this interval. The circulation delay was recently found to be 9.9 ± 2.4 s in patients with severe OSA (129). In the majority of patients (67%) this represented a two-breath delay, indicating that the increase in chemical drive would extend for one breath beyond breath 1. In 19% the delay was the duration of only one breath (i.e., no expected increase in drive beyond breath 1), while in the remaining 14% the delay would result in chemical drive increasing for two breaths beyond breath 1.

The rate of increase in chemical drive during and following an obstructive event is determined by 1) how much E decreases during the event; 2) factors that determine the rate of change in pulmonary gas tensions per unit reduction in E [so called plant gain (17, 50, 53, 67, 125, 130)]. including lung volume, cardiac output, and metabolic rate; and 3) the dynamic response of the respiratory centers to these gas changes (i.e., controller gain; for reviews see 17, 50, 53, 67, 125, 130). There is much indirect evidence to suggest that, on average, for a given reduction in alveolar E the rate of increase in chemical drive is higher in OSA patients than in normal subjects. Thus:

1) Hudgel et al. (42) found the dynamic response of E to a single breath increase in inspired CO₂ to be higher in OSA patients than in normal subjects. This study was, however, done in awake upright subjects breathing oxygen.

2) The use of proportional assist ventilation (PAV) superimposed on CPAP (to stabilize the airway) was recently introduced to measure loop gain during sleep (130). Loop gain is the product of plant gain (i.e., see 2 above) and controller gain (i.e., see 3 above) when respiratory mechanics are constant (50, 53). It is a dimensionless number that describes the ratio [ventilatory response/initial ventilatory disturbance]. When the ratio is 1.0, spontaneous periodicity develops. When loop gain is <1, oscillations in breathing will not occur spontaneously. However, higher values in the range between zero and 1.0 reflect a greater rate of rise in chemical drive following a given reduction in E, and a greater tendency to oscillate if other destabilizing factors, such as unstable mechanics or arousals, are added (130). In normal subjects loop gain is very low (usually <0.3; Refs. 69, 70, 116, 117). In patients with OSA, loop gain is almost always less than 1.0 (115, 130), indicating that, without additional destabilizing factors, OSA patients would not be unstable. However, loop gain measured on CPAP is, on average, higher in OSA patients than in normal subjects, indicating that, for a given reduction in E, the rate of rise in chemical drive per unit reduction in E should be higher in such patients. Wellman et al. (115) found only a weak correlation between loop gain and the AHI. This is not surprising since, as described above, loop gain measured on CPAP reflects only some of the factors that determine the rate of rise in chemical drive (another important factor being the severity of the hypopnea), and the rate of rise is itself only one of many factors that determine instability in OSA patients, the others being arousal threshold and intensity, magnitude of T_ER, relation between chemical drive and flow beyond T_ER (Fig. 4), and the discontinuous flow response at the time of opening. Interestingly, however, these authors (115) found a much stronger correlation between loop gain and AHI in a subgroup of patients in whom P_Close was near zero, thereby illustrating the interaction between severity of upper airway mechanics and chemical control instability.

3) The average rate of increase in negative intrathoracic pressure (P/t) during naturally occurring obstructive events in OSA patients ranged between 1.0 and 2.0 cmH₂O/s in different studies (4, 5, 6, 99, 121, 136). This is to be compared with a rate of 0.35–0.70 cmH₂O/s in normal subjects subjected to airway occlusion during sleep (7–9). Although these rates cannot be directly compared because the lower lung volume in the obese OSA patients amplifies the relation between muscle activation and occlusion pressure (for review, see Ref. 132), the differences in P/t are more than can be accounted for by such a mechanism.

Recently, the breath-by-breath increase in E during non-rapid eye movement (NREM) sleep on CPAP was determined following step changes in inspired gases in 21 patients with severe OSA [AHI = 91 ± 24 h^–1 (129)]. This approach has the advantage of expressing the rate of change in chemical drive in the same units in which T_ER and arousal threshold can be expressed (i.e., %increase, relative to eupneic drive, required to elicit either response). In this fashion the interrelation between different variables that contribute to instability can be examined in individual patients. By use of a range of inspired gas mixtures, it was possible to estimate the %increase in chemical drive following a moderately severe obstructive hypopnea or an apnea associated with a modest 4% reduction in O₂ saturation (129). The average response is shown in Fig. 6 (heavy solid line) along with the range observed (dashed lines). As expected from the circulation delay, there was no increase in drive until breath 3. Beyond breath 3 the rate of increase was, on average, remarkably high [134 ± 77% of eupneic drive between breaths 3 and 5 (Fig. 6)]. As with all other variables that affect breathing stability in these patients, the rate of increase in chemical drive in the span of two breaths (breath 3 to breath 5 in this case) varied enormously among patients (49–380% of eupneic drive). Thus the impact of circulatory delay on postevent increase in chemical drive is highly variable and can be extremely large. Clearly, for any given patient, the rate of rise of chemical drive would be lower or much lower if the hypopnea were not as severe, or higher if desaturation was >4%.

View larger version (12K): [in this window] [in a new window]   Fig. 6. Estimated breath-by-breath increase in chemical drive following an obstructive apnea or a severe hypopnea associated with 4% reduction in O2 saturation in patients with severe obstructive apnea. Solid line, average response. Dashed lines, highest and lowest responses observed. Note the dramatic average increase in chemical drive between breaths 3 and 5 but also the large variability in the response among different patients. Solid dot, average arousal threshold (TA) in the same patients. TER1 and TER2 are 2 representative examples of the effective recruitment threshold, one above and one below arousal threshold. See text for additional explanations. Modified from Ref. 129.

Without arousal [i.e., (T_A – T_ER) > (circulation delay x rate of increase in drive)] the overshoot is not as likely to be large (Fig. 5). However, a large overshoot may still occur if T_ER is high, or if chemical drive increases substantially during the circulation delay, resulting in more complete airway opening.

It is important to note that the various factors that contribute to an overshoot, and hence instability, show little or no correlation with each other (129). Thus the mechanisms contributing to instability vary considerably among patients (129). All the patients represented in Fig. 6 had continuous instability during sleep. Yet some had a low rate of rise of chemical drive, while others had low T_ER and/or high arousal threshold (129). Accordingly, instability develops when a critical combination of these variables exists that results in a sufficiently large overshoot.

DIFFERENCES BETWEEN SUBJECTS WITH AND WITHOUT OSA

Virtually all the recent studies leading to the conceptual framework presented in this review were done on patients with collapsible airways and at least some degree of OSA (127–129). It is clear that within this patient group there are major differences in the response to sleep-induced obstructions and that these differences largely account for the range of polysomnographic abnormalities observed (i.e., range of AHI). The important question arises, however, as to whether the range of responses in these patients is representative of the responses in the population at large. While more research needs to be done in this area, limited data suggest that the range of responses to upper airway obstruction is similar in OSA patients and in others with more favorable pharyngeal mechanics. Thus King et al. (56) found that when normal subjects are made to sleep with negative airway pressure they develop OSA that is indistinguishable from that observed with natural collapse in OSA patients. Notably, the AHI varied widely among subjects (from near zero to 90 h^–1), event duration was similar to that found in natural OSA (18 s on average), and most but not all events were terminated by arousal (56). From the data presented, it is also clear that, as in patients with natural OSA (127), these subjects had periods of stable breathing at the same negative pressure that was associated with OSA at other times.

SUMMARY OF DETERMINANTS OF POLYSOMNOGRAPHIC FEATURES OF OBSTRUCTIVE SLEEP DISORDERS

Figure 7 is a flow chart that summarizes how different control mechanisms determine the response to the primary anatomic problem and, hence, the polysomnographic features. At the top of the chart, the anatomic defect is not expressed in absolute terms (i.e., P_Close or _MAX0) but as the relation between the anatomic defect (quantified by _MAX0) and the individual's flow demand. This is to emphasize that the same anatomic defect may or not be significant depending on the metabolic and gas exchange status. Distinction is made between _MAX0 being higher or lower than 30% of peak flow demand. This is because when _MAX0 is >30% peak unloaded flow (i.e., mild/moderate hypopnea at eupneic drive), compensation is possible without the need to increase _MAX, whereas with more severe obstructions at eupneic drive a stable response requires an increase in _MAX, which is a less reliable and potentially more unstable response. With milder obstructions (left side of Fig. 7 chart), the entire range of polysomnographic features, from no abnormality to steady flow limitation to OSA, may occur, depending on T_ER and the potency of the duty cycle response. With more severe hypopneas and apneas an equally wide range of manifestations may result, depending on the relation between T_ER and arousal threshold, absolute arousal threshold, and loop gain (which incorporates circulation delay, and dynamic plant and controller gains). Regardless of the initial severity, the final responses may be normocapnic or hypercapnic, depending on the steady-state response to CO₂ and hypoxia and on arousal threshold. Daytime hypercapnia may result particularly in the presence of comorbidities {e.g., chronic obstructive pulmonary disease [the overlap syndrome (114) or obesity-associated restrictive disorder (obesity hypoventilation syndrome; Ref. 78)]}. A low T_ER mitigates hypercapnia even when CO₂ and hypoxic responses are low since the change in gas tensions required to increase _MAX to a sustainable level would still be small. This accounts for the absence of a hypercapnic version of stable breathing on the far right of the chart in Fig. 7.

View larger version (15K): [in this window] [in a new window]   Fig. 7. Flow chart showing how different polysomnographic pictures (boxed terms) can arise following sleep-induced obstructive events. FL, flow limitation; LG, loop gain; OSA, obstructive sleep apnea; PUF, peak unloaded flow rate; SS, steady state; TA, increase in chemical drive required to cause arousal; TER, increase in chemical drive required to open the airway without arousal; UARS, upper airway resistance syndrome; MAX0, maximum flow at atmospheric pressure in the absence of pharyngeal dilator activity; mild/mod, mild to moderate. See text for details.

When either T_ER or arousal threshold is relatively low, or when rate of rise of chemical drive is high (more severe obstructions and/or high loop gain), such protracted (minutes) hypopnea/apneas are not possible and cycling frequency will tend to be high.

The percentage of time spent in instability, the other component of the AHI, is related to how far removed from stability the system is, relative to how much changes in the stability factors can occur spontaneously during the night. Some of the factors that determine stability change from time to time during sleep. Chief among these is arousal threshold (2). However, other factors may also change, although this needs experimental confirmation. For example, T_ER may be different in different body or head positions because of position-related differences in passive mechanics. Alternatively, passive mechanics may change through the night as a result of changes in vascularity or surface tension properties of the pharynx. Lung-carotid transit time may also change with cardiac function through the night. If the mechanism of instability is such that the within-night changes in stability factors cannot bring the system to a stable state, cycling will persist throughout sleep and the AHI will equal cycling frequency. For example, if T_ER is sufficiently higher than arousal threshold that the spontaneous changes in arousal threshold cannot place the two thresholds in a stable relationship, there cannot be stable time. On the other hand, if the constellation of stability factors is such that the spontaneous changes that occur during the night are enough to bring the system to a stable state, cycling will occur at times but not at others. For example, entering a deeper sleep state, or a change in body or head position may abort cycling, and vice versa.

Finally, the form an obstructive event takes is related to the severity of the mechanical abnormality and the extent of ventilatory overshoot. When passive P_Close is negative the obstructive event can only be a hypopnea. When passive P_Close is >0, the obstructive event may be either a hypopnea or an apnea, depending on whether the overshoot reduced chemical drive below T_ER. In either case, if the overshoot is sufficiently large to reduce chemical drive below the apneic threshold (101), the obstructive event may be preceded by a period of central apnea (i.e., mixed apnea). Two additional phenomena may help fashion the obstructive event although their actual contributions remain uncertain. First, the ventilatory overshoot following an obstructive event is a form of active hyperpnea. Such active hyperpneas do not disappear promptly as the stimulus that caused them is removed. A trailing central stimulation follows for a variable period [short-term potentiation (STP) or afterdischarge (23–25)]. A potent afterdischarge mechanism may mitigate the effect of washing away the chemical stimulus during the overshoot and maintain respiratory drive at a higher level in the overshoot's aftermath than it would otherwise be (66, 125). Such an action may avert central apneas at the beginning of the events or result in an obstructive hypopnea where an obstructive apnea may have otherwise followed. The afterdischarge was found to be, on average, less potent in patients with severe OSA than in normal subjects (28, 51), suggesting that an attenuated afterdischarge mechanism may contribute to the development of mixed apneas in some patients. Second, the pharynx displays viscoelastic properties in that its elastic recoil (i.e., collapsibility; e.g., P_Close) is least following a sustained inflation (e.g., immediately after reduction of CPAP) and increases in a time-dependent manner following removal of the inflating force (98, 127). During the ventilatory phase following an obstructive event the pharynx is maintained open for a finite period. Depending on how strongly these viscoelastic properties are expressed, collapsibility will decrease to a variable extent during the ventilatory phase and increase again later as the pharynx narrows. Such time-dependent changes in passive mechanics may delay the onset of obstruction in the aftermath of the overshoot and may, as in the case of the afterdischarge mechanism, help convert some obstructive apneas into hypopneas.

GRANTS

This review was supported by the Canadian Institutes of Health Research.

DISCLOSURES

M. Younes holds several patents on technology related to mechanical ventilation. Some of these have been licensed to ventilator companies, and Dr. Younes receives royalties from these licenses. None of these patents or licenses has any relation to the work or subject matter of this review article.

FOOTNOTES

Address for reprint requests and other correspondence: M. Younes, 5011 Roblin Blvd., Winnipeg, Manitoba, Canada R3R 0G2 (e-mail: mkyounes{at}shaw.ca)

¹ In theory, _MAX can increase through mechanisms that do not involve recruitment of pharyngeal dilators, such as increased caudal traction associated with increases in lung volume (108), or reduction of inspiratory effort when negative effort dependence exists (43). However, once an obstructive event is initiated, neither of these other mechanisms is available to increase _MAX since lung volume cannot increase and inspiratory effort will increase rather than decrease. Thus the only mechanism available to increase _MAX is recruitment of pharyngeal dilators.

² Some investigators have interpreted the linear relation between airway pressure and _MAX as indicating that the pharynx behaves as a Starling resistor (103). According to this interpretation, the pressure intercept of the relation (referred to as P_CRIT) is the pressure at which the airway closes because extramural pressure exceeds intramural pressure (i.e., analogous to P_Close) and the inverse slope of the relation above P_CRIT (i.e., P_AW/Flow) is the resistance upstream of the flow-limiting segment [hence referred to as nasal (R_N) or upstream (R_US) resistance (103)]. Thus, according to this model, _MAX increases linearly with upstream pressure simply because the gradient between upstream pressure and the fixed pressure at the flow-limiting segment (i.e., P_CRIT) is higher. In the opinion of this writer, the Starling model is inappropriate in the context of pharyngeal flow limitation since such a treatment assumes that, in the presence of flow limitation, luminal pressure at the flow-limiting segment and the resistance of the upstream segment are unaffected by upstream pressure (i.e., both values are constant). This assumption is untenable if only because the experimentally determined inverse slope of the P_AW vs. _MAX relation [25 cmH₂O·l^–1·s (12, 98, 127); range 10–62 (127)], which, according to the Starling model, is the value of the constant upstream resistance, is an order of magnitude greater than the directly measured resistance of the nose/nasopharynx (e.g., 1a, 43). The more reasonable explanation for the relation between _MAX and upstream pressure is that only a fraction of the change in upstream pressure is dissipated against the fairly low upstream resistance so that most of the pressure change is transmitted to the flow-limiting segment, changing its area and compliance and, according to tube law, altering the maximum flow that can be transmitted. For example, with a 10-cmH₂O increase in pressure at the external airway, _MAX increases 0.35 l/s on average (127). The resistance of the airway upstream from the choke point (i.e., nose and nasopharynx) is quite small over this flow range [2–3 cmH₂O·l^–1·s (1a, 43)] so that less than 1.0 cmH₂O of the total 10-cmH₂O change in P_AW is dissipated against upstream resistance. The rest is transmitted to the flow-limiting segment, increasing its area and decreasing its compliance according to that segment's pressure-area relation (43). Hence, the slope of the P_AW-_MAX relation is largely a function of the pressure-area relation of the flow-limiting segment.

³ An increase in heart rate may occur beyond UA opening in the absence of cortical arousal, but this is to be expected as a physiological response to the large hemodynamic and lung volume changes following resolution of the obstruction (comparable, for example, to sinus arrythmia).

⁴ In the presence of complete obstruction (i.e., no bulk flow into the chest), Respitrace amplitude reflects gas decompression and chest deformation related to the magnitude of negative intrathoracic pressure.

REFERENCES

1. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research: the Report of an American Academy of Sleep Medicine Task Force. Sleep 22: 667–689, 1999.[Web of Science][Medline]
1. Anch AM, Remmers JE, Bunce H 3rd. Supraglottic airway resistance in normal subjects and patients with occlusive sleep apnea. J Appl Physiol 53: 1158–1163, 1982.[Abstract/Free Full Text]
2. Berry RB, Asyali MA, McNellis MI, Khoo MC. Within-night variation in respiratory effort preceding apnea termination and EEG delta power in sleep apnea. J Appl Physiol 85: 1434–1441, 1998.[Abstract/Free Full Text]
3. Berry RB, Gleeson K. Respiratory arousal from sleep: mechanisms and significance. Sleep 20: 654–675, 1997.[Web of Science][Medline]
4. Berry RB, Kouchi KG, Der DE, Dickel MJ, Light RW. Sleep apnea impairs the arousal response to airway occlusion. Chest 109: 1490–1496, 1996.[CrossRef][Web of Science][Medline]
5. Berry RB, Kouchi K, Bower J, Prosise G, Light RW. Triazolam in patients with obstructive sleep apnea. Am J Respir Crit Care Med 151: 450–454, 1995.[Abstract]
6. Berry RB, Kouchi KG, Bower JL, Light RW. Effect of upper airway anesthesia on obstructive sleep apnea. Am J Respir Crit Care Med 151: 1857–1861, 1995.[Abstract]
7. Berry RB, Light RW. Effect of hyperoxia on the arousal response to airway occlusion during sleep in normal subjects. Am Rev Respir Dis 146: 330–334, 1992.[Web of Science][Medline]
8. Berry RB, Mahutte CK, Light RW. Effect of hypercapnia on the arousal response to airway occlusion during sleep in normal subjects. J Appl Physiol 74: 2269–2275, 1993.[Abstract/Free Full Text]
9. Berry RB, McCasland CR, Light RW. The effect of triazolam on the arousal response to airway occlusion during sleep in normal subjects. Am Rev Respir Dis 146: 1256–1260, 1992.[Web of Science][Medline]
10. Berry RB, McNellis MI, Kouchi K, Light RW. Upper airway anesthesia reduces phasic genioglossus activity during sleep apnea. Am J Respir Crit Care Med 156: 127–132, 1997.[Abstract/Free Full Text]
11. Berry RB, White DP, Roper J, Pillar G, Fogel RB, Stanchina M, Malhotra A. Awake negative pressure reflex response of the genioglossus in OSA patients and normal subjects. J Appl Physiol 94: 1875–1882, 2003.[Abstract/Free Full Text]
12. Boudewyns A, Punjabi N, Van de Heyning PH, De Backer WA, O'Donnell CP, Schneider H, Smith PL, Schwartz AR. Abbreviated method for assessing upper airway function in obstructive sleep apnea. Chest 118: 1031–1040, 2000.[CrossRef][Web of Science][Medline]
13. Boyd JH, Petrof BJ, Hamid Q, Fraser R, Kimoff RJ. Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med 170: 541–546, 2004.[Abstract/Free Full Text]
14. Carlson DM, Carley DW, Onal E, Lopata M, Basner RC. Acoustically induced cortical arousal increases phasic pharyngeal muscle and diaphragmatic EMG in NREM sleep. J Appl Physiol 76: 1553–1559, 1994.[Abstract/Free Full Text]
15. Carlson DM, Onal E, Carley DW, Lopata M, Basner RC. Palatal muscle electromyogram activity in obstructive sleep apnea. Am J Respir Crit Care Med 152: 1022–1027, 1995.[Abstract]
16. Carrera M, Barbé F, Sauleda J, Tomás M, Gómez C, Agustí AG. Patients with obstructive sleep apnea exhibit genioglossus dysfunction that is normalized after treatment with continuous positive airway pressure. Am J Respir Crit Care Med 159: 1960–1966, 1999.[Abstract/Free Full Text]
17. Cherniack NS, Longobardo GS. Mathematical models of periodic breathing and their usefulness in understanding cardiovascular and respiratory disorders. Exp Physiol 91: 295–305, 2006.[Abstract/Free Full Text]
18. Clark SA, Wilson CR, Satoh M, Pegelow D, Dempsey JA. Assessment of inspiratory flow limitation invasively and noninvasively during sleep. Am J Respir Crit Care Med 158: 713–722, 1998.[Abstract/Free Full Text]
19. Cunningham DJC, Robbins PA, Wolff CB. Integration of respiratory responses to changes in alveolar partial pressures of CO2 and O2 and in arterial pH. In: Handbook of Physiology. The Respiratory System. Control of Breathing. Bethesda, MD: Am. Physiol. Soc., 1986, sect. 3, vol. II, pt. 2, chapt. 15, p. 475–528.
20. Dawson SV, Elliott EA. Wave-speed limitation on expiratory flow-a unifying concept. J Appl Physiol 43: 498–515, 1977.[Abstract/Free Full Text]
21. Dempsey JA, Skatrud JB, Jacques AJ, Ewanowski SJ, Woodson BT, Hanson PR, Goodman B. Anatomic determinants of sleep-disordered breathing across the spectrum of clinical and nonclinical male subjects. Chest 122: 840–851, 2002.[CrossRef][Web of Science][Medline]
22. Eastwood PR, Szollosi I, Platt PR, Hillman DR. Comparison of upper airway collapse during general anaesthesia and sleep. Lancet 359: 1207–1209, 2002.[CrossRef][Web of Science][Medline]
23. Eldridge FL. Posthyperventilation breathing: different effects of active and passive hyperventilation. J Appl Physiol 34: 422–430, 1973.[Free Full Text]
24. Eldridge FL. Central neural respiratory stimulatory effect of active respiration. J Appl Physiol 37: 723–735, 1974.[Free Full Text]
25. Eldridge FL, Gill-Kumar P. Central neural respiratory drive and afterdischarge. Respir Physiol 40: 49–63, 1980.[CrossRef][Web of Science][Medline]
26. Fogel RB, Malhotra A, White DP. Sleep. 2. Pathophysiology of obstructive sleep apnoea/hypopnoea syndrome. Thorax 59: 159–163, 2004.[Abstract/Free Full Text]
27. Fogel RB, Trinder J, White DP, Malhotra A, Raneri J, Schory K, Kleverlaan D, Pierce RJ. The effect of sleep onset on upper airway muscle activity in patients with sleep apnoea versus controls. J Physiol 564: 549–562, 2005.[Abstract/Free Full Text]
28. Georgopoulus D, Giannouli E, Tsara V, Argiropoulou P, Patakas D, Anthonisen NR. Respiratory short-term poststimulus potentiation (after-discharge) in patients with obstructive sleep apnea. Am Rev Respir Dis 146: 1250–1255, 1992.[Web of Science][Medline]
29. Gleadhill IC, Schwartz AR, Schubert N, Wise RA, Permutt S, Smith PL. Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis 143: 1300–1303, 1991.[Web of Science][Medline]
30. Gleeson K, Zwillich CW, White DP. The influence of increasing ventilatory effort on arousal from sleep. Am Rev Respir Dis 142: 295–300, 1990.[Web of Science][Medline]
31. Golbin JM, Somers VK, Caples SM. Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension. Proc Am Thorac Soc 5: 200–206, 2008.[Abstract/Free Full Text]
32. Gold AR, Marcus CL, Dipalo F, Gold MS. Upper airway collapsibility during sleep in upper airway resistance syndrome. Chest 121: 1531–1540, 2002.[CrossRef][Web of Science][Medline]
33. Guilleminault C, Li K, Chen NH, Poyares D. Two-point palatal discrimination in patients with upper airway resistance syndrome, obstructive sleep apnea syndrome, and normal control subjects. Chest 122: 866–870, 2002.[CrossRef][Web of Science][Medline]
34. Guilleminault C, Stoohs R, Clerk A, Cetel M, Maistros P. A cause of excessive daytime sleepiness. The upper airway resistance syndrome. Chest 104: 781–787, 1993.[CrossRef][Web of Science][Medline]
35. Haxhiu MA, van Lunteren E, Mitra J, Cherniack NS. Comparison of the response of diaphragm and upper airway dilating muscle activity in sleeping cats. Respir Physiol 70: 183–193, 1987.[Web of Science][Medline]
36. Horner RL. Motor control of the pharyngeal musculature and implications for the pathogenesis of obstructive sleep apnea. Sleep 1996: 827–53, 1996.
37. Horner RL, Innes JA, Morrell MJ, Shea SA, Guz A. The effect of sleep on reflex genioglossus muscle activation by stimuli of negative airway pressure in humans. J Physiol 476: 141–151, 1994.[Abstract/Free Full Text]
38. Horner RL, Innes JA, Murphy K, Guz A. Evidence for reflex upper airway dilator muscle activation by sudden negative airway pressure in man. J Physiol 436: 15–29, 1991.[Abstract/Free Full Text]
39. Horner RL, Liu X, Gill H, Nolan P, Liu H, Sood S. Effects of sleep-wake state on the genioglossus vs. diaphragm muscle responses to CO₂ in rats. J Appl Physiol 92: 878–887, 2002.[Abstract/Free Full Text]
40. Horner RL, Shea SA, McIvor J, Guz A. Pharyngeal size and shape during wakefulness and sleep in patients with obstructive sleep apnoea. QJM 72: 719–735, 1989.[Abstract/Free Full Text]
41. Hosselet JJ, Norman RG, Ayappa I, Rapoport DM. Detection of flow limitation with a nasal cannula/pressure transducer system. Am J Respir Crit Care Med 157: 1461–1467, 1998.[Web of Science][Medline]
42. Hudgel DW, Gordon EA, Thanakitcharu S, Bruce EN. Instability of ventilatory control in patients with obstructive sleep apnea. Am J Respir Crit Care Med 158: 1142–1149, 1998.[Abstract/Free Full Text]
43. Isono S, Feroah TR, Hajduk EA, Brant R, Whitelaw WA, Remmers JE. Interaction of cross-sectional area, driving pressure, and airflow of passive velopharynx. J Appl Physiol 83: 851–859, 1997.[Abstract/Free Full Text]
44. Isono S, Morrison DL, Launois SH, Feroah TR, Whitelaw WA, Remmers JE. Static mechanics of the velopharynx of patients with obstructive sleep apnea. J Appl Physiol 75: 148–154, 1993.[Abstract/Free Full Text]
45. Isono S, Remmers JE, Tanaka A, Sho Y, Sato J, Nishino T. Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol 82: 1319–1326, 1997.[Abstract/Free Full Text]
46. Isono S, Tanaka A, Tagaito Y, Ishikawa T, Nishino T. Influences of head positions and bite opening on collapsibility of the passive pharynx. J Appl Physiol 97: 339–346, 2004.[Abstract/Free Full Text]
47. Jordan AS, Wellman A, Heinzer RC, Lo YL, Schory K, Dover L, Gautam S, Malhotra A, White DP. Mechanisms used to restore ventilation after partial upper airway collapse during sleep in humans. Thorax 62: 861–867, 2007.[Abstract/Free Full Text]
48. Jordan AS, White DP. Pharyngeal motor control and the pathogenesis of obstructive sleep apnea. Respir Physiol Neurobiol 160: 1–7, 2008.[CrossRef][Web of Science][Medline]
49. Kaleth AS, Chittenden TW, Hawkins BJ, Hargens TA, Guill SG, Zedalis D, Gregg JM, Herbert WG. Unique cardiopulmonary exercise test responses in overweight middle-aged adults with obstructive sleep apnea. Sleep Med 8: 160–168, 2007.[CrossRef][Web of Science][Medline]
50. Khoo MC. Determinants of ventilatory instability and variability. Respir Physiol 122: 167–182, 2000.[CrossRef][Web of Science][Medline]
51. Khoo MC, Berry RB. Modeling the interaction between arousal and chemical drive in sleep-disordered breathing. Sleep 19: S167–S169, 1996.[Web of Science][Medline]
52. Khoo MC, Gottschalk A, Pack AI. Sleep-induced periodic breathing and apnea: a theoretical study. J Appl Physiol 70: 2014–2024, 1991.[Abstract/Free Full Text]
53. Khoo MC, Kronauer RE, Strohl KP, Slutsky AS. Factors inducing periodic breathing in humans: a general model. J Appl Physiol 53: 644–659, 1982.[Abstract/Free Full Text]
54. Kimoff RJ, Cheong TH, Olha AE, Charbonneau M, Levy RD, Cosio MG, Gottfried SB. Mechanisms of apnea termination in obstructive sleep apnea. Role of chemoreceptor and mechanoreceptor stimuli. Am J Respir Crit Care Med 149: 707–714, 1994.[Abstract]
55. Kimoff RJ, Sforza E, Champagne V, Ofiara L, Gendron D. Upper airway sensation in snoring and obstructive sleep apnea. Am J Respir Crit Care Med 164: 250–255, 2001.[Abstract/Free Full Text]
56. King ED, O'Donnell CP, Smith PL, Schwartz AR. A model of obstructive sleep apnea in normal humans. Role of the upper airway. Am J Respir Crit Care Med 161: 1979–1984, 2000.[Abstract/Free Full Text]
57. Kirkness JP, Christenson HK, Garlick SR, Parikh R, Kairaitis K, Wheatley JR, Amis TC. Decreased surface tension of upper airway mucosal lining liquid increases upper airway patency in anaesthetised rabbits. J Physiol 547: 603–611, 2003.[Abstract/Free Full Text]
58. Kirkness JP, Madronio M, Stavrinou R, Wheatley JR, Amis TC. Relationship between surface tension of upper airway lining liquid and upper airway collapsibility during sleep in obstructive sleep apnea hypopnea syndrome. J Appl Physiol 95: 1761–1766, 2003.[Abstract/Free Full Text]
59. Kirkness JP, Schwartz AR, Patil SP, Pichard LE, Marx JJ, Smith PL, Schneider H. Dynamic modulation of upper airway function during sleep: a novel single-breath method. J Appl Physiol 101: 1489–1494, 2006.[Abstract/Free Full Text]
60. Kirkness JP, Schwartz AR, Schneider H, Punjabi NM, Maly JJ, Laffan AM, McGinley BM, Magnuson T, Schweitzer M, Smith PL, Patil SP. Contribution of male sex, age, and obesity to mechanical instability of the upper airway during sleep. J Appl Physiol 104: 1618–1624, 2008.[Abstract/Free Full Text]
61. Kuna ST, Smickley J. Response of genioglossus muscle activity to nasal airway occlusion in normal sleeping adults. J Appl Physiol 64: 347–353, 1988.[Abstract/Free Full Text]
62. Launois SH, Feroah TR, Campbell WN, Issa FG, Morrison D, Whitelaw WA, Isono S, Remmers JE. Site of pharyngeal narrowing predicts outcome of surgery for obstructive sleep apnea. Am Rev Respir Dis 147: 182–188, 1993.[Web of Science][Medline]
63. Lin CC, Hsieh WY, Chou CS, Liaw SF. Cardiopulmonary exercise testing in obstructive sleep apnea syndrome. Respir Physiol Neurobiol 150: 27–34, 2006.[CrossRef][Web of Science][Medline]
64. Lin CC, Lin CK, Wu KM, Chou CS. Effect of treatment by nasal CPAP on cardiopulmonary exercise test in obstructive sleep apnea syndrome. Lung 182: 199–212, 2004.[CrossRef][Web of Science][Medline]
65. Lo YL, Jordan AS, Malhotra A, Wellman A, Heinzer RC, Schory K, Dover L, Fogel RB, White DP. Genioglossal muscle response to CO₂ stimulation during NREM sleep. Sleep 29: 470–477, 2006.[Web of Science][Medline]
66. Longobardo G, Evangelisti CJ, Cherniack NS. Effects of neural drives on breathing in the awake state in humans. Respir Physiol 129: 317–333, 2002.[CrossRef][Web of Science][Medline]
67. Longobardo GS, Gothe B, Goldman MD, Cherniack NS. Sleep apnea considered as a control system instability. Respir Physiol 50: 311–333, 1982.[CrossRef][Web of Science][Medline]
68. Mathew OP. Upper airway negative-pressure effects on respiratory activity of upper airway muscles. J Appl Physiol 56: 500–505, 1984.[Abstract/Free Full Text]
69. Meza S, Mendez M, Ostrowski M, Younes M. Susceptibility to periodic breathing with assisted ventilation during sleep in normal subjects. J Appl Physiol 85: 1929–1940, 1998.[Abstract/Free Full Text]
70. Meza S, Younes M. Ventilatory stability during sleep studied with proportional assist ventilation (PAV). Sleep 19: S164–S166, 1996.[Web of Science][Medline]
71. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 89: 1571–1579, 1992.[Web of Science][Medline]
72. Mezzanotte WS, Tangel DJ, White DP. Influence of sleep onset on upper-airway muscle activity in apnea patients versus normal controls. Am J Respir Crit Care Med 153: 1880–1887, 1996.[Abstract]
73. Milic-Emili J, Grunstein MM. Drive and timing components of ventilation. Chest 70: 131–133, 1976.[Web of Science][Medline]
74. Morrison DL, Launois SH, Isono S, Feroah TR, Whitelaw WA, Remmers JE. Pharyngeal narrowing and closing pressures in patients with obstructive sleep apnea. Am Rev Respir Dis 148: 606–611, 1993.[Web of Science][Medline]
75. Mortimore IL, Douglas NJ. Palatal muscle EMG response to negative pressure in awake sleep apneic and control subjects. Am J Respir Crit Care Med 156: 867–873, 1997.[Abstract/Free Full Text]
76. Nguyen AT, Jobin V, Payne R, Beauregard J, Naor N, Kimoff RJ. Laryngeal and velopharyngeal sensory impairment in obstructive sleep apnea. Sleep 28: 585–593, 2005.[Web of Science][Medline]
77. Okabe S, Chonan T, Hida W, Satoh M, Kikuchi Y, Takishima T. Role of chemical drive in recruiting upper airway and inspiratory intercostal muscles in patients with obstructive sleep apnea. Am Rev Respir Dis 147: 190–195, 1993.[Web of Science][Medline]
78. Olson AL, Zwillich C. The obesity hypoventilation syndrome. Am J Med 118: 948–956, 2005.[CrossRef][Web of Science][Medline]
79. Olson LG, Strohl KP. Airway secretions influence upper airway patency in the rabbit. Am Rev Respir Dis 137: 1379–1381, 1988.[Web of Science][Medline]
80. Onal E, Leech JA, Lopata M. Dynamics of respiratory drive and pressure during NREM sleep in patients with occlusive apneas. J Appl Physiol 58: 1971–1974, 1985.[Abstract/Free Full Text]
81. Onal E, Lopata M. Respiratory timing during NREM sleep in patients with occlusive sleep apnea. J Appl Physiol 61: 1444–1448, 1986.[Abstract/Free Full Text]
82. Onal E, Lopata M, O'Connor TD. Diaphragmatic and genioglossal electromyogram responses to isocapnic hypoxia in humans. Am Rev Respir Dis 124: 215–217, 1981.[Web of Science][Medline]
83. Onal E, Lopata M, O'Connor TD. Diaphragmatic and genioglossal electromyogram responses to CO₂ rebreathing in humans. J Appl Physiol 50: 1052–1055, 1981.[Abstract/Free Full Text]
84. Onal E, Lopata M, O'Connor T. Pathogenesis of apneas in hypersomnia-sleep apnea syndrome. Am Rev Respir Dis 125: 167–174, 1982.[Web of Science][Medline]
85. Pack AI. Advances in sleep-disordered breathing. Am J Respir Crit Care Med 173: 7–15, 2006.[Abstract/Free Full Text]
86. Patil SP, Punjabi NM, Schneider H, O'Donnell CP, Smith PL, Schwartz AR. A simplified method for measuring critical pressures during sleep in the clinical setting. Am J Respir Crit Care Med 170: 86–93, 2004.[Abstract/Free Full Text]
87. Patil SP, Schneider H, Marx JJ, Gladmon E, Schwartz AR, Smith PL. Neuromechanical control of upper airway patency during sleep. J Appl Physiol 102: 547–556, 2007.[Abstract/Free Full Text]
88. Patil SP, Schneider H, Schwartz AR, Smith PL. Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest 132: 325–337, 2007.[CrossRef][Web of Science][Medline]
89. Penzel T, Moller M, Becker HF, Knaack L, Peter JH. Effect of sleep position and sleep stage on the collapsibility of the upper airways in patients with sleep apnea. Sleep 24: 90–94, 2001.[Web of Science][Medline]
90. Phillipson EA, Sullivan CE. Arousal: the forgotten response to respiratory stimuli. Am Rev Respir Dis 118: 807–809, 1978.[Web of Science][Medline]
91. Pierce R, White D, Malhotra A, Edwards JK, Kleverlaan D, Palmer L, Trinder J. Upper airway collapsibility, dilator muscle activation and resistance in sleep apnoea. Eur Respir J 30: 345–353, 2007.[Abstract/Free Full Text]
92. Pillar G, Malhotra A, Fogel RB, Beauregard J, Slamowitz DI, Shea SA, White DP. Upper airway muscle responsiveness to rising PCO₂ during NREM sleep. J Appl Physiol 89: 1275–1282, 2000.[Abstract/Free Full Text]
93. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 44: 931–938, 1978.[Free Full Text]
94. Ryan CM, Bradley TD. Pathogenesis of obstructive sleep apnea. J Appl Physiol 99: 2440–2450, 2005.[Abstract/Free Full Text]
95. Ryan CF, Lowe AA, Li D, Fleetham JA. Three-dimensional upper airway computed tomography in obstructive sleep apnea: a prospective study in patients treated by uvulopalatopharyngoplasty. Am Rev Respir Dis 144: 428–432, 1991.[Web of Science][Medline]
96. Schneider H, Patil SP, Canisius S, Gladmon EA, Schwartz AR, O'Donnell CP, Smith PL, Tankersley CG. Hypercapnic duty cycle is an intermediate physiological phenotype linked to mouse chromosome 5. J Appl Physiol 95: 11–19, 2003.[Abstract/Free Full Text]
97. Schwab RJ, Gupta KB, Gefter WB, Metzger LJ, Hoffman EA, Pack AI. Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Am J Respir Crit Care Med 152: 1673–1689, 1995.[Abstract]
98. Schwartz AR, O'Donnell CP, Baron J, Schubert N, Alam D, Samadi SD, Smith PL. The hypotonic upper airway in obstructive sleep apnea: role of structures and neuromuscular activity. Am J Respir Crit Care Med 157: 1051–1056, 1998.[Abstract/Free Full Text]
99. Sforza E, Krieger J, Petiau C. Arousal threshold to respiratory stimuli in OSA patients: evidence for a sleep-dependent temporal rhythm. Sleep 22: 69–75, 1999.[Web of Science][Medline]
100. Sforza E, Petiau C, Weiss T, Thibault A, Krieger J. Pharyngeal critical pressure in patients with obstructive sleep apnea syndrome. Clinical implications. Am J Respir Crit Care Med 159: 149–157, 1999.[Abstract/Free Full Text]
101. Skatrud JB, Dempsey JA. Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol 55: 813–822, 1983.[Abstract/Free Full Text]
103. Smith PL, Wise RA, Gold AR, Schwartz AR, Permutt S. Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol 64: 789–795, 1988.[Abstract/Free Full Text]
104. Stoohs R, Guilleminault C. Snoring during NREM sleep: respiratory timing, esophageal pressure and EEG arousal. Respir Physiol 85: 151–167, 1991.[CrossRef][Web of Science][Medline]
105. Stanchina ML, Malhotra A, Fogel RB, Ayas N, Edwards JK, Schory K, White DP. Genioglossus muscle responsiveness to chemical and mechanical stimuli during non-rapid eye movement sleep. Am J Respir Crit Care Med 165: 945–949, 2002.[Abstract/Free Full Text]
106. Strohl KP, Redline S. Nasal CPAP therapy, upper airway muscle activation, and obstructive sleep apnea. Am Rev Respir Dis 134: 555–557, 1986.[Web of Science][Medline]
107. Suratt PM, McTier RF, Wilhoit SC. Upper airway muscle activation is augmented in patients with obstructive sleep apnea compared with that in normal subjects. Am Rev Respir Dis 137: 889–894, 1988.[Web of Science][Medline]
108. Tangel DJ, Mezzanotte WS, Sandberg EJ, White DP. Influences of NREM sleep on the activity of tonic vs. inspiratory phasic muscles in normal men. J Appl Physiol 73: 1058–1066, 1992.[Abstract/Free Full Text]
109. Van de Graaff WB. Thoracic influence on upper airway patency. J Appl Physiol 65: 2124–2131, 1988.[Abstract/Free Full Text]
110. Van der Touw T, Crawford AB, Wheatley JR. Effects of a synthetic lung surfactant on pharyngeal patency in awake human subjects. J Appl Physiol 82: 78–85, 1997.[Abstract/Free Full Text]
111. van Lunteren E, Strohl KP. The muscles of the upper airways. Clin Chest Med 7: 171–188, 1986.[Web of Science][Medline]
112. Vincken W, Guilleminault C, Silvestri L, Cosio M, Grassino A. Inspiratory muscle activity as a trigger causing the airways to open in obstructive sleep apnea. Am Rev Respir Dis 135: 372–377, 1987.[Web of Science][Medline]
113. Watanabe T, Isono S, Tanaka A, Tanzawa H, Nishino T. Contribution of body habitus and craniofacial characteristics to segmental closing pressures of the passive pharynx in patients with sleep-disordered breathing. Am J Respir Crit Care Med 165: 260–265, 2002.[Abstract/Free Full Text]
114. Weitzenblum E, Chaouat A, Kessler R, Canuet M. Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 5: 237–241, 2008.[Abstract/Free Full Text]
115. Wellman A, Jordan AS, Malhotra A, Fogel RB, Katz ES, Schory K, Edwards JK, White DP. Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 170: 1225–1232, 2004.[Abstract/Free Full Text]
116. Wellman A, Malhotra A, Fogel RB, Edwards JK, Schory K, White DP. Respiratory system loop gain in normal men and women measured with proportional-assist ventilation. J Appl Physiol 94: 205–212, 2003.[Abstract/Free Full Text]
117. Wellman A, Malhotra A, Jordan AS, Schory K, Gautam S, White DP. Chemical control stability in the elderly. J Physiol 581: 291–298, 2007.[Abstract/Free Full Text]
118. Wheatley JR, Mezzanotte WS, Tangel DJ, White DP. Influence of sleep on genioglossus muscle activation by negative pressure in normal men. Am Rev Respir Dis 148: 597–605, 1993.[Web of Science][Medline]
119. Wheatley JR, Tangel DJ, Mezzanotte WS, White DP. Influence of sleep on response to negative airway pressure of tensor palatini muscle and retropalatal airway. J Appl Physiol 75: 2117–2124, 1993.[Abstract/Free Full Text]
120. White DP. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 172: 1363–1370, 2005.[Abstract/Free Full Text]
121. Wilcox PG, Pare PD, Road JD, Fleetham JA. Respiratory muscle function during obstructive sleep apnea. Am Rev Respir Dis 142: 533–539, 1990.[Web of Science][Medline]
122. Wilson SL, Thach BT, Brouillette RT, Abu-Osba YK. Upper airway patency in the human infant: influence of airway pressure and posture. J Appl Physiol 48: 500–504, 1980.[Abstract/Free Full Text]
123. Wilson TA, Rodarte JR, Butler JP. Wave-speed and viscous flow limitation. In: Handbook of Physiology. The Respiratory System. Mechanics of Breathing. Bethesda, MD: Am. Physiol. Soc., 1986, vol. 3, pt. I, chapt. 5, p. 55–61.
124. Worsnop C, Kay A, Pierce R, Kim Y, Trinder J. Activity of respiratory pump and upper airway muscles during sleep onset. J Appl Physiol 85: 908–920, 1998.[Abstract/Free Full Text]
125. Younes M. The physiologic basis of central apnea and periodic breathing. Curr Pulmonol 10: 265–326, 1989.
126. Younes M. Mechanisms of respiratory load compensation. In: Regulation of Breathing, edited by Dempsey JA, Pack AI. New York: Dekker, 1995, vol. 79, p. 867–922 (Lung Biol Health Dis Ser).
127. Younes M. Contributions of upper airway mechanics and control mechanisms to severity of obstructive apnea. Am J Respir Crit Care Med 168: 645–658, 2003.[Abstract/Free Full Text]
128. Younes M. Role of arousals in the pathogenesis of obstructive sleep apnea. Am J Respir Crit Care Med 169: 623–633, 2004.[Abstract/Free Full Text]
129. Younes M, Ostrowski M, Atkar R, Laprairie J, Siemens A, Hanly P. Mechanisms of breathing instability in patients with obstructive sleep apnea. J Appl Physiol 103: 1929–1941, 2007.[Abstract/Free Full Text]
130. Younes M, Ostrowski M, Thompson W, Leslie C, Shewchuk W. Chemical control stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med 163: 1181–1190, 2001.[Abstract/Free Full Text]
131. Younes M, Park E, Horner RL. Pentobarbital sedation increases genioglossus respiratory activity in sleeping rats. Sleep 30: 478–488, 2007.[Web of Science][Medline]
132. Younes M, Riddle W. A model for the relation between respiratory neural and mechanical outputs. I. Theory. J Appl Physiol 51: 963–978, 1981.[Abstract/Free Full Text]
133. Younes M, Riddle W, Polacheck J. A model for the relation between respiratory neural and mechanical outputs. III. Validation. J Appl Physiol 51: 990–1001, 1981.[Abstract/Free Full Text]
134. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328: 1230–1235, 1993.[Abstract/Free Full Text]
135. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 291: 2013–2016, 2004.[Free Full Text]
136. Zamagni M, Sforza E, Boudewijns A, Petiau C, Krieger J. Respiratory effort. A factor contributing to sleep propensity in patients with obstructive sleep apnea. Chest 109: 651–658, 1996.[CrossRef][Web of Science][Medline]

This article has been cited by other articles:

				V. Pialoux, P. J. Hanly, G. E. Foster, J. V. Brugniaux, A. E. Beaudin, S. E. Hartmann, M. Pun, C. T. Duggan, and M. J. Poulin Effects of Exposure to Intermittent Hypoxia on Oxidative Stress and Acute Hypoxic Ventilatory Response in Humans Am. J. Respir. Crit. Care Med., November 15, 2009; 180(10): 1002 - 1009. [Abstract] [Full Text] [PDF]

				R. L. Horner Emerging principles and neural substrates underlying tonic sleep-state-dependent influences on respiratory motor activity Phil Trans R Soc B, September 12, 2009; 364(1529): 2553 - 2564. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Free All Versions of this Article: 105/5/1389    most recent 90408.2008v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Younes, M. Search for Related Content PubMed PubMed Citation Articles by Younes, M.